Search

everythinglearnresearchcommunity

for

Search:↓

Treatment with a hormone agonist can reduce excess male hormones in postmenopausal women without surgery.

A 63-year-old woman's male-like symptoms were caused by a rare testosterone-producing ovarian tumor, treated by removing her ovaries and fallopian tubes.

Testosterone Replacement Therapy can improve sexual health in postmenopausal women with low sexual desire, but more research is needed on its long-term effects.

A 68-year-old woman developed male traits due to a tumor in her ovary, which was removed, returning her hormone levels to normal.

The document concludes that doctors should check for frontal fibrosing alopecia in patients with acquired hyperpigmentation and that early treatment is important.

Upper eyelid hyperpigmentation can help diagnose facial lichen planus pigmentosus in patients with frontal fibrosing alopecia.

Bilateral ovarian hyperthecosis is a rare but treatable cause of increased facial hair in postmenopausal women.

A woman's rare ovarian tumor was treated with surgery, which stopped her symptoms and normalized her hormone levels.

Frontal fibrosing alopecia can occur in children, not just postmenopausal women.

Hydroxychloroquine effectively reduces symptoms of frontal fibrosing alopecia, especially in the first 6 months.

Topical estrogen helps hair growth in menopausal women with no major side effects.

Managing frontal fibrosing alopecia and lichen planus pigmentosus is challenging due to resistant hair loss and skin discoloration.

The document concludes that treatments for female hair loss and excessive hair growth are temporary and not well-studied.

Frontal fibrosing alopecia can affect men's beards and leads to permanent hair loss.

Methotrexate may help stabilize frontal fibrosing alopecia.

Dermoscopy helps diagnose frontal fibrosing alopecia by identifying specific scalp features.

Androgenetic alopecia can be treated with minoxidil and finasteride, requiring long-term use and patient cooperation.

A young man with an unusual type of scarring hair loss suggests a possible new variant of a known scalp condition.

The higher dose supplement was more effective in treating female hair loss.

Higher doses of oestradiol implants improve bone density in postmenopausal women.

"Male-pattern" hair loss is common in women, especially after menopause, and doesn't always mean there's a problem with hormone balance.

Taking DHEA for a year is generally safe for postmenopausal women but may cause acne and more facial hair without improving metabolism or aging.

Women with scarring alopecia have a lower quality of life and more anxiety and depression than those with non-scarring alopecia.

In 2017, Spanish dermatologists most often prescribed minoxidil and finasteride for male hair loss, and minoxidil and oral contraceptives for premenopausal female hair loss.

Frontal fibrosing alopecia is a poorly understood condition with increasing cases and unclear treatment effectiveness.

In Spain, dermatologists most commonly prescribe topical minoxidil and oral finasteride for male hair loss, and topical minoxidil and oral contraceptives for female hair loss. The use of oral dutasteride and oral minoxidil has significantly increased over the past three years.

Dermatologists recommend oral dutasteride for male hair loss, low-dose oral minoxidil for female hair loss, and a multidisciplinary approach for young patients, with caution during pregnancy.

Early treatment and multidisciplinary care are key to managing Frontal Fibrosing Alopecia and preventing further hair loss.

Some types of hair loss can be reversed, others are permanent, and treatments vary by type.

Trichoscopy helps tell apart Lichen planopilaris and Frontal fibrosing alopecia from other hair loss conditions.